Stamford Therapeutics Consortium — Stamford, Connecticut

Public research footprint of Stamford Therapeutics Consortium, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Obesity · Overweight · SARS-CoV-2 · Systemic Lupus Erythematosus

Recently updated registry entries

NCT07239336 — Study of DONQ52 in Active Celiac Disease (Recruiting)
NCT05975099 — A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme… (Completed)
NCT06672939 — A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stamford Therapeutics Consortium?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.